Contemporary women are under more and more heavy pressure both in the workplace and in life. Compared with men, women’s special physical reasons and gender-specific risk factors are more likely to cause health problems in some diseases. The whole society is caring for women’s health. Taking breast cancer as an example, the incidence rate in China has increased year by year in recent years, and it shows a trend of rejuvenation. Early detection and early treatment are the key paths for disease prevention and control. Shenrui Medical uses innovative technology to launch an integrated full-cycle management plan for women’s care for AI, and escorts the health of the goddess with the power of AI.
Breast cancer ranks first in the incidence of malignant tumors among women in China, and it is becoming younger. The compact structure, lump and structural distortion of Asian women’s breast are easily influenced by glands, which is a difficult point in X-ray diagnosis of breast. Shenrui Medical took the lead in solving this problem through the independent innovation of AI advanced algorithm for ultra-small object detection in high noise environment. Dr.Wise? breast X-ray AI medical auxiliary diagnosis system introduced by Shenrui Medical can automatically detect calcification, mass, asymmetric shadow, structural distortion and other lesions, and analyze the characteristics of calcification shape and distribution, mass shape, edge and density, make BI-RADS classification and form a structured report. At present, this product has obtained the first and only category III certificate of breast AI products in China.
Shenrui Medical deeply cultivates the application of artificial intelligence technology in the medical field and promotes the integration of product research and development and clinical diagnosis path; At the same time, based on the application scenario, combined with Shenrui medical breast disease database and multi-modal scientific research platform, the multi-dimensional data about breast diseases in the hospital are precipitated into data assets, and relying on the dual AI engine of "image+data", it can provide doctors with an overall solution for disease exploration and management from the whole cycle of disease screening, diagnosis, evaluation and scientific research, and provide strong AI innovative technical support for improving the level of breast cancer diagnosis and treatment and real-world research.
Shenrui Medical cooperated with the Cancer Hospital affiliated to Fudan University to build a data platform for health management of breast cancer in the whole course, and fully empowered medical teaching and research management in the field of breast cancer based on data intelligence technology. The platform was built in early 2020 and completed by the end of 2021. Up to now, the breast cancer database has included more than 4 million visits. The platform has the functions of intelligent collection, cleaning and structuring of multi-modal data of breast cancer patients in the whole course, which greatly improves the efficiency of scientific research and accelerates the output of results, thus providing comprehensive decision support for clinical diagnosis and treatment, clinical scientific research, patient service, regional cooperation and other scenarios, and promoting the improvement of teaching, research and management of single-disease medicine in disciplines and even regions.
Through the self-developed medical multimodal research platform, Shenrui Medical has cooperated with many domestic medical institutions to carry out a series of research on the direction of breast diseases, so as to improve the performance of breast disease-related detection and diagnosis algorithms. At present, nearly 20 scientific research papers have been published in top conferences and SCI journals, and one of the scientific research achievements on automatic detection of breast X-ray images has been included in TPMAI (IF 24.314), a heavyweight journal in AI field. At present, Shenrui Medical uses AI technology to integrate the most advanced academic achievements in the field of breast diseases, such as current target detection, case segmentation, and order regression, and occupies an international leading position.
With the popularization and application of new technologies, Shenrui Medical is gradually overcoming difficulties, breaking through bottlenecks and escorting public health. Not only in women’s health management, but also in caring for children’s growth and development, managing major chronic diseases and preventing cancer. With the diversified AI product matrix and the innovative spirit of continuous exploration, we practice the vision of "Dr. Shen Rui makes it no longer difficult to see a doctor" and are committed to contributing wisdom to the health of the whole people. Love her, love them, and Shenrui Medical contributes to a healthy China with wisdom. I wish all female compatriots happiness, health and beauty on Goddess Day.
